Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are aged 18 or older at the time of signing consent forms.
- People who are willing and able to follow the study procedures, as determined by the study investigator.
- People who have already had surgery related to their condition and have enough stored tissue samples (from either the main tumor or a lymph node) available for a specific blood-based DNA test, as outlined in the study's laboratory guidelines.
- People who agree in writing to take part in the study and allow their personal health information to be used for research purposes.
Who may not be able to join:
- People who have received treatment before surgery (called neoadjuvant therapy) to shrink the tumor prior to their operation.
- People whose scans or imaging show that the cancer has spread to other parts of the body (metastatic disease).
- People whose lymph node results show only a very tiny number of cancer cells, specifically what is medically classified as "N1 micrometastasis" or isolated tumor cells (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yara Abdou, MD, UNC Lineberger Comprehensive Cancer Center
Phone: 919-445-4872
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of participants have post-operative circulating tumor DNA (ctDNA) positive
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.